Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Dyne Therapeutics(DYN) the Revenue is 0 (--%), Meet estimate;the EBIT is -181.66 M (-56.89%), Miss estimate;the EPS is -1.08 (-11.34%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITMiss expectations
-0.18B56.89%
-0.13B12.50%
-0.05B44.39%
EPSMiss expectations
-1.0811.34%
-0.748722.82%
-0.331334.16%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf